K905521

Substantially Equivalent

CEDIA(R) THEOPHYLLINE ASSAY/MODIFICATION

Applicant: Microgenics Corp.
Product code: LER
Advisory panel: Clinical Toxicology
Date received: 1990-12-07
Decision date: 1990-12-26
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Concord, CA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.